A Phase I dose-escalation trial, conducted at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and multiple sites nationwide, has shown that a new gene therapy treatment for high-grade gliomas — the most aggressive brain tumors — is safe and improves patient survival. Having passed this milestone, the treatment will move on to more advanced trials.
April 25th, 2017 - AAN BostonSave The Date
NeuroUpdate Feb 9-11, 2017Register Now
Moving Day 2015More . . .
ALS Team Accepts Ice Bucket Challenge
Nicole M. Wilson, a neuroscience Ph.D. candidate, won the Women in Neurotrauma Research (WiNTR) Award after competing in the trainee poster competition at the 2016 National Neurotrauma Society Symposium. The WiNTR award is given annually to recognize the top poster presentation by a woman. The trainee poster competition consisted of the top 22 (out of 377) graduate students and post-doctoral associates.
Treating rats with an experimental drug at three months following a traumatic brain injury improves their memory and learning ability, as reported in a new study published in the The Journal of Neuroscience. The drug is currently under development, and is being tested as a potential therapy for TBI by researchers at The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine.